Edx Medical Group (LON:EDX – Get Free Report) insider Christopher Evans purchased 197,500 shares of the firm’s stock in a transaction that occurred on Friday, November 6th. The shares were bought at an average price of GBX 8 per share, for a total transaction of £15,800.
Edx Medical Group Trading Up 1.4%
EDX traded up GBX 0.10 during trading on Monday, reaching GBX 7.50. The company had a trading volume of 237,845 shares, compared to its average volume of 74,193. The business’s 50 day moving average is GBX 8.71. The company has a market capitalization of £32.35 million and a PE ratio of -5.04. Edx Medical Group has a 52 week low of GBX 6 and a 52 week high of GBX 13.
Edx Medical Group (LON:EDX – Get Free Report) last posted its quarterly earnings data on Thursday, September 3rd. The company reported GBX (1.50) earnings per share for the quarter.
Edx Medical Group Company Profile
EDX Medical Group plc is a United Kingdom-based medical diagnostics company focused on developing and commercializing clinical tests intended to support the detection, diagnosis and management of disease. Its work is centered on molecular and genetic testing, with an emphasis on providing more personalized information to healthcare professionals and patients.
The company’s activities include the development of diagnostic and screening products for applications such as cancer and other significant health conditions.
Featured Stories
- Five stocks we like better than Edx Medical Group
- Want to Escape the AI Sell-Off? This ETF Offers a Surprising Alternative
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
Receive News & Ratings for Edx Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edx Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
